Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes

被引：41
|
作者：
Preiser, Jean-Charles [1 ]
Provenzano, Bruna [1 ]
Mongkolpun, Wasineeart [1 ]
Halenarova, Katarina [1 ]
Cnop, Miriam [2 ,3 ]
机构：
[1] Free Univ Brussels, Dept Intens Care, Brussels, Belgium
[2] Free Univ Brussels, Erasmus Hosp, Div Endocrinol, Brussels, Belgium
[3] Free Univ Brussels, Ctr Diabet Res, Brussels, Belgium
来源：
ANESTHESIOLOGY | 2020年 / 133卷 / 02期
关键词：
COTRANSPORTER-2; INHIBITORS; CARDIOVASCULAR EVENTS; LACTIC-ACIDOSIS; BLOOD-GLUCOSE; METFORMIN; HYPERGLYCEMIA; DEATH; RISK; MORTALITY; SURGERY;
D O I：
10.1097/ALN.0000000000003237
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
[No abstract available]
引用
收藏
页码：430 / 438
页数：9
相关论文
共 50 条
  • [41] Comparison of Glucose-Lowering Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Gu, Shuyan
    Hu, Xiaoqian
    Zhen, Xuemei
    Shi, Lizheng
    Shao, Hui
    Sun, Xueshan
    Gu, Yuxuan
    Huang, Minzhuo
    Dong, Hengjin
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (18)
  • [42] Cardiovascular prevention with glucose-lowering drugs in type 2 diabetes: An evidence-based approach to the categories of primary and secondary prevention
    Mannucci, Edoardo
    Silverii, Giovanni Antonio
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3435 - 3443
  • [43] Influence of the glucose-lowering rate on left ventricular function in patients with type 2 diabetes and coronary heart disease
    Wu, Weihua
    Sun, Zhenjie
    Li, Qian
    Wang, Mingli
    Miao, Jiajing
    Zheng, Zhaohui
    Sun, Lifang
    Huang, Jinwei
    Wang, Ying
    Zhang, Hongmei
    Hu, Chunxiang
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2012, 26 (02) : 83 - 88
  • [44] Use of Glucose-Lowering Agents in Diabetes and CKD
    Alicic, Radica Z.
    Neumiller, Joshua J.
    Galindo, Rodolfo J.
    Tuttle, Katherine R.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (12): : 2589 - 2607
  • [45] Drug–Drug Interactions with Sodium-Glucose Cotransporters Type 2 (SGLT2) Inhibitors, New Oral Glucose-Lowering Agents for the Management of Type 2 Diabetes Mellitus
    André J. Scheen
    Clinical Pharmacokinetics, 2014, 53 : 295 - 304
  • [46] The Role of Pharmacogenetics in Drug Disposition and Response of Oral Glucose-Lowering Drugs
    N. van Leeuwen
    J. J. Swen
    H.-J. Guchelaar
    L. M. ’t Hart
    Clinical Pharmacokinetics, 2013, 52 : 833 - 854
  • [47] A modern approach to glucose-lowering therapy in frail older people with type 2 diabetes mellitus
    Abdelhafiz, Ahmed H.
    Pennells, Daniel
    Sinclair, Alan J.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (02) : 95 - 98
  • [48] Treatment trajectories for Danish individuals with type 2 diabetes in the era of emerging glucose-lowering therapies
    Pottegard, Anton
    Andersen, Jacob H.
    Sondergaard, Jens
    Rasmussen, Lotte
    Kildegaard, Helene
    Vilsboll, Tina
    Thomsen, Reimar W.
    DIABETES OBESITY & METABOLISM, 2024, 26 (11): : 4996 - 5004
  • [49] Personalizing Glucose-Lowering Therapy in Patients with Type 2 Diabetes and Cardiovascular Disease
    Inzucchi, Silvio E.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 137 - +
  • [50] Chronic Kidney Disease in Type 2 Diabetes: Optimizing Glucose-Lowering Therapy
    Bakris, George
    JOURNAL OF FAMILY PRACTICE, 2019, 68 (08): : S1 - S6
12345